T-Cell Lymphoma Clinical Trials

A listing of T-Cell Lymphoma medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 175 clinical trials
Anti-ICOS Monoclonal Antibody MEDI-570 in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma Follicular Variant or Angioimmunoblastic T-cell Lymphoma

This phase I trial studies the side effects and best dose of anti-inducible T-cell co-stimulator (ICOS) monoclonal antibody MEDI-570 in treating patients with peripheral T-cell lymphoma

neutrophil count
monoclonal protein
large cell lymphoma
monoclonal antibodies
monoclonal antibody therapy
  • 1105 views
  • 17 Jan, 2021
  • 17 locations
PD-1 Antibody Chidamide Lenalidomide and Gemcitabine for Peripheral T-cell Lymphoma

To observe the safety, tolerability and clinical effects of PD-1, chidamide, lenalidomide and gemcitabine in the treatment of newly diagnosed and relapse/refractory peripheral T-cell lymphoma

t-cell lymphoma
lenalidomide
refractory peripheral t-cell lymphoma
measurable disease
chidamide
  • 1 views
  • 18 May, 2020
  • 1 location
Micro Needle Array-Doxorubicin (MNA-D) in Patients With Cutaneous T-cell Lymphoma (CTCL)

The study hypothesis is that in situ MNA-directed chemo-immunotherapy using doxorubicin will kill tumor cells locally and alter the tumor microenvironment to induce durable systemic tumor-specific immunity. The purpose of this study is to test a new method of experimental treatment for CTCL, using small adhesive-like patches (a micro-needle applicator …

tumor cells
psoralen
extracorporeal photopheresis
lymphoma
bexarotene capsules
  • 23 views
  • 25 Dec, 2020
  • 1 location
Targeted Drug Combined With CHOP in the Treatment of Newly Diagnosed Peripheral T-cell Lymphoma

This prospectivemulti-centeropen-label, controlled study will evaluate the efficacy and safety of targeted drug in combination with CHOP in treatment of newly diagnosed peripheral T-cell

t-cell lymphoma
measurable disease
  • 0 views
  • 27 Jul, 2020
Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With CD30-Positive Peripheral T-cell Lymphoma

This phase II trial studies the side effects and how well brentuximab vedotin and combination chemotherapy work in treating patients with CD30-positive peripheral T-cell lymphoma. Brentuximab

combination chemotherapy
monoclonal protein
intestinal t-cell lymphoma
monoclonal antibodies
leukemia
  • 7 views
  • 19 Jul, 2020
  • 8 locations
Lenalidomide and Sintilimab for Relapsed/Refractory NK/T-cell Lymphoma

The purpose of this study is to evaluate the efficacy and safety of Sintilimab in combination with lenalidomide in the treatment of Relapsed/Refractory NK/T-cell lymphoma patients who failed

  • 0 views
  • 13 May, 2020
  • 1 location
Phase I/II Study Evaluating AUTO4 in Patients With TRBC1 Positive T Cell Lymphoma

The purpose of this study is to test the safety and efficacy of AUTO4 a CAR T cell treatment targeting TRBC1 in patients with relapsed or refractory TRBC1 positive selected T-Non-Hodgkin Lymphoma.

hodgkin's disease
neutrophil count
large cell lymphoma
lymphoma
t-cell lymphoma
  • 35 views
  • 04 Nov, 2020
  • 5 locations
Romidepsin and Lenalidomide in Treating Patients With Previously Untreated Peripheral T-Cell Lymphoma

The purpose of this study is to evaluate how safe and effective the combination of the study drugs romidepsin and lenalidomide is for treating patients with peripheral t-cell lymphoma (PTCL) who

intestinal t-cell lymphoma
revlimid
panniculitis
lymphoma
extranodal nk/t-cell lymphoma
  • 131 views
  • 24 Feb, 2020
  • 5 locations
Sintilimab and Decitabine for Patients With Relapsed/Refractory or Advanced NK/T-cell Lymphoma

The purpose of this study is to evaluate the efficacy and safety of Sintilimab in combination with decitabine in the treatment of Relapsed/Refractory or advanced NK/T-cell lymphoma patients

renal function
  • 0 views
  • 14 May, 2020
  • 1 location
Brentuximab Vedotin and Lenalidomide in Patients With Relapsed/ Refractory T-cell Lymphoma or Hodgkin Lymphoma

This study is investigating the combination of Brentuximab vedotin and lenalidomide in the treatment of relapsed/refractory peripheral T cell lymphoma or cutaneous T cell lymphoma or Hodgkin

neutrophil count
hodgkin's disease
platelet count
lymphoma
cutaneous t-cell lymphoma
  • 0 views
  • 07 Oct, 2020
  • 1 location